Literature DB >> 1547634

Combined modality preoperative therapy for unresectable rectal cancer.

B Percarpio1, J Bitterman, K Sabbath, F Alfano, R Ruszkowski, J Bowen.   

Abstract

Locally advanced rectal cancer has been a surgical challenge because of fixation of the primary tumor to the boney pelvis or to other pelvic soft tissues. During a 12-month period seven patients with locally advanced adenocarcinoma of the rectum were treated preoperatively with simultaneous pelvic irradiation (4500-5040 cGy) and infusion chemotherapy (5-fluorouracil 1000 mg per m2 per day over 96 hours and mitomycin 10 mg per m2. Tolerance was reasonable and all patients underwent successful resection of the primary lesion. Two patients had a complete response to preoperative combined modality therapy with no cancer found in the surgical specimen. With a short follow-up period, all patients have experienced satisfactory healing and none have suffered local or distant recurrence. The results of this limited series are encouraging for future clinical trials.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1547634

Source DB:  PubMed          Journal:  Conn Med        ISSN: 0010-6178


  3 in total

1.  Suppository delivery of 5-fluorouracil in rectal cancer.

Authors:  S Galandiuk; W Wrightson; L Marr; S Myers; R V LaRocca
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

2.  The effects of hyperbaric oxygen therapy on experimental colon anastomosis after preoperative chemoradiotherapy.

Authors:  Ramazan Yildiz; Mehmet Fatih Can; Gokhan Yagci; Taner Ozgurtas; Metin Guden; Mehmet Gamsizkan; Erkan Ozturk; Sadettin Cetiner
Journal:  Int Surg       Date:  2013 Jan-Mar

3.  Development of in situ gelling and bio adhesive 5-Fluorouracil enema.

Authors:  Lu-Lu Wang; Wen-Sheng Zheng; Shao-Hua Chen; Xia-Qin Fang
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.